Evaluation of Residual Minimum Response with Free Serum Light Chains in Patients with Multiple Myeloma Diagnosis

被引：0
|
作者：
Ramiro, Espinoza, III
Juan, Labardini
Eduardo, Cervera
Perez, Karen
Barrera, Cristina
Candelaria, Myrna
Sosa, Alejandro
Garcia, Laura
Lopez, Celia
Zapata, Magnolia Vieyraand Nidia
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5372
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Analysis of Free Serum Light Chains in Patients Suffering from Multiple Myeloma Complicated by Light-Chain Amyloidosis
    Usnarska-Zubkiewicz, Lidia
    Holojda, Jadwiga
    Debski, Jakub
    Zubkiewicz-Zarebska, Anna
    Zagocka, Ewa
    Kuliczkowski, Kazimierz
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 23 (04): : 531 - 538
  • [32] Practical use of serial measurements of serum free light chains to monitor response to treatment of multiple myeloma.
    Bradwell, AR
    Galvin, GP
    Mead, GP
    Carr-Smith, HD
    BLOOD, 2003, 102 (11) : 376B - 377B
  • [33] Evaluation of serum free light chains and outcome in multiple myeloma patients with an intact monoclonal immunoglobulin treated with autologous stem cell transplantation
    Trieu, Y.
    Xu, W.
    Chen, C. I.
    Kukreti, V.
    Mikhael, J.
    Trudel, S.
    Reece, D. E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 206 - 207
  • [34] The serum determination of the ratio of light chains to diagnosis has a prognostic value in multiple myeloma
    Macro, Margareth
    HEMATOLOGIE, 2007, 13 (03): : 135 - 135
  • [35] PROGNOSTIC CONTRIBUTION OF UNINVOLVED SERUM FREE LIGHT CHAINS (USFLC) IN MULTIPLE MYELOMA (MM)
    Koulieris, E.
    Maltezas, D.
    Tzenou, T.
    Kafassi, N.
    Bartzis, V.
    Bitsanis, K.
    Efthymiou, A.
    Vardounioti, I.
    Karali, V.
    Nikolaou, E.
    Dimou, M.
    Tsaftaridis, P.
    Angelopoulou, M.
    Panayiotidis, P.
    Pangalis, G.
    Kyrtsonis, M.
    HAEMATOLOGICA, 2012, 97 : 601 - 601
  • [36] Immunoassay for detection of free light chains in serum of patients with nonsecretory myeloma.
    Bradwell, AR
    Tang, LX
    Drayson, M
    Drew, RL
    BLOOD, 2000, 96 (11) : 271B - 271B
  • [37] Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response
    Moustafa, Muhamad Alhaj
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Buadi, Francis
    Gertz, Morie
    Lacy, Martha
    Kapoor, Prashant
    Hayman, Suzanne
    Dingli, David
    Kyle, Robert
    Kumar, Shaji
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S238 - S238
  • [38] Myeloma monitoring using serum free light chains in patients with renal involvment
    Flisar, Ziva
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 256 - 256
  • [39] Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response
    Moustafa, Muhamad Alhaj
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Buadi, Francis K.
    Gertz, Morie A.
    Lacy, Martha Q.
    Kapoor, Prashant
    Hayman, Suzanne R.
    Dingli, David
    Kyle, Robert
    Kumar, Shaji
    BLOOD, 2014, 124 (21)
  • [40] Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?
    Cruz Cardenas, Maria
    Inigo, Belen
    Ortega, Isabel
    Angeles Palomar, Maria
    Menendez, Marina
    Plaza, Paula
    Martinez-Novillo, Mercedes
    Benavente, Celina
    FRONTIERS IN ONCOLOGY, 2022, 12
12345